Medicated Skin Products Market in Pakistan to 2014 (OTC Healthcare)

Introduction

This databook provides key data and information on the Medicated Skin Products Market in Pakistan (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.

Scope

• Market,category and segment level information on value, volume, and expenditure & consumption, with historic (2003-2008) and forecast (2009-2013) data
• Category level company and brand share as well as distribution share information for 2007 and 2008

Highlights

The medicated skin products category was valued at PKR436.4m ($6.2m) in 2009, representing a CAGR of 7.3% since 2004.

By the end of 2014, the medicated skin products category will be worth PKR572.4m ($8.1m), with an expected CAGR of 5.6% between 2009 and 2014.

The medicated skin products market was led by anti-fungals (representing 34.3% of the total value) followed by anti-bacterials and acne treatments, with a 26.9% and 21.9% market share, respectively. Disinfectants and other medicated skin products constitute the remaining segments with a 9.8% and 7.2% market share, respectively.

Reckitt Benckiser PLC is the market leader with a 19.1% share of the market.

Reasons to Purchase

• Develop business strategies by understanding the quantitative trends within the Medicated Skin Products Market in Pakistan (OTC Healthcare)
• Design effective marketing and sales strategies by identifying key market categories and segments
• Identify key players within the market to plan lucrative M&A, partnerships and agreements